A
Agilent Technologies Inc (A) Sec Form 8K
Agilent Technologies Inc (NYSE: A) Sec Form 8K
Agilent Technologies Inc (A) Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader
Agilent Technologies Inc (NYSE: A) FY 2026 Other Release
Agilent Technologies Inc (A) 44th Annual J.P. Morgan Healthcare Conference
Agilent Technologies Inc (NYSE: A) FY 2026 Corporate Conference
Agilent Technologies Inc (A) Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
Agilent Technologies Inc (NYSE: A) FY 2026 Other Release
Agilent Technologies Inc (A) Sec Form 8K
Agilent Technologies Inc (NYSE: A) Sec Form 8K
Agilent Technologies Inc (A) Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026
Agilent Technologies Inc (NYSE: A) FY 2026 Other Release
Agilent Technologies Inc (A) Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States
Agilent Technologies Inc (NYSE: A) FY 2026 Other Release
Agilent Technologies Inc (A) Q1 2026 Earnings Call Transcript
Agilent Technologies Inc (NYSE: A) Q1 2026 Earnings Call dated Feb. 25, 2026 Corporate Participants: Tejas Savant — Vice President,…
Agilent Technologies Inc (A) Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions
Agilent Technologies Inc (NYSE: A) FY 2026 Other Release
Agilent Technologies Inc (A) Sec Form 8K
Agilent Technologies Inc (NYSE: A) Sec Form 8K